THE ONLY CGM

THAT WORKS FOR UP TO

3 MONTHS† STRAIGHT

With the Eversense 90-Day CGM System, you can actively manage your diabetes simply and with confidence. The Eversense CGM System provides continuous glucose monitoring for up to 90 days via an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management. If you're on insulin, discover what Eversense can do for you.

Eversense CGM System Sets a New Standard

Improve Diabetes Management

Helps to support better diabetes management.

Pills Icon

Accuracy unaffected when taking Tylenol (Acetaminophen) and/or Vitamin C.2

Radar Icon

Detects 95% of hypoglycemic and 99% of hyperglycemic events.3

Blood Cells Icon

Shown to significantly reduce A1c by 0.5%.1

Device Icon

Transmitter can be removed and replaced without wasting the sensor.

Eversense Sets a New Standard

 

Helps to support better diabetes management.
 

 

Accuracy unaffected when taking Tylenol (Acetaminophen) and/or Vitamin C.2

 

Detects 95% of hypoglycemic and 99% of hyperglycemic events.3

 

Shown to significantly reduce A1c by 0.5%.1
 

 

Transmitter can be removed and replaced without wasting the sensor.

Sensor Thumbnail

Sensor

Professionally inserted by a
Health Care Provider.



Remains accurate, even if you sleep on it or while you exercise.1 

Rests comfortably just under the skin.

LEARN MORE >
Transmitter Thumbnail

Transmitter

Removable, rechargeable and water resistant.†

† Water resistant when submerged in 1 meter of water for up to 30 minutes.

Sends data every 5 minutes to your mobile device.

Provides on-body alerts so you don't always have to have your mobile device nearby.

LEARN MORE >
Mobile App Thumbnail

Mobile App

Receive real-time glucose measurements on your compatible mobile phone or smart watch. No need for a separate receiver.


Track events like meals and workouts and show them right on your graph to help identify trends.

Share your data with friends, family and your Health Care Provider.

LEARN MORE >

Start enjoying the long-term convenience and comfort of 90-Day CGM today!
And in early Spring of 2022, be among the first to get** on the NEW Eversense E3 CGM system that lasts up to 6 months. 

Get in touch to learn more about how to get started on Eversense. Please complete your contact details and an Ascensia Diabetes Care representative will follow up with you shortly.
Curious about cost? Ascensia Diabetes Care can assist you in navigating your insurance coverage.

 

Plus! Savings of up to $300 toward out-of-pocket cost for each Eversense 90-day sensor and transmitter (up to $1200) may be available for eligible patients.‡

Learn more

*Field is required



 

The sensor placement went very well. I felt nothing, no pain, no discomfort. There are no stitches, no sutures, just two steri strips and a bandage.

Robert, Eversense CGM User

See why Robert loves Eversense*

Watch Video
  1. Christiansen MP, Klaff LJ, Brazg R, et al. A Prospective Multicenter Evaluation of the Accuracy of a Novel Implanted Continuous Glucose Sensor: PRECISE II. Diabetes Technology & Therapeutics. 2018; 20(3): 197–206
  2. Lorenz C, Sandoval W, Mortellaro M. Interference Assessment of Various Endogenous and Exogenous Substances on the Performance of the Eversense Long-Term Implantable Continuous Glucose Monitoring System. Diabetes Technology and Therapeutics. 2018; 20(5): 344-352. DOI: 10.1089/dia.2018.0028
  3. Christiansen MP, KlaffLJ, Bailey TS, Brazg R, Carlson G, Tweden KS. A Prospective Multicenter Evaluation of the Accuracy and Safety of an Implanted Continuous Glucose Sensor: The PRECISION Study. Diabetes Technology & Therapeutics. 2019; 21(5): 231 -237. doi:10.1089/dia.2019.0020.

The Bluetooth® word mark and logos are registered trademarks owned by Bluetooth SIG, Inc., and any use of such marks by Ascensia Diabetes Care is under license.

 

Disclaimer

The Eversense® E3 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to 180 days in persons with diabetes age 18 and older. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are still required for calibration primarily one time a day after day 21, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense E3 CGM System is a prescription device; patients should talk to their health care provider to learn more.
For safety information click here.

Eversense, Eversense E3 Continuous Glucose Monitoring and the Eversense logo are trademarks of Senseonics, Incorporated. Ascensia, and the Ascensia Diabetes Care logo are trademarks and/or registered trademarks of Ascensia Diabetes Care Holdings AG. All other trademarks are properties of their respective owners and are used solely for informative purposes. No relationship or endorsement should be inferred or implied.

Apple Watch® is a product of Apple, Inc., and may be separately purchased from an authorized Apple retailer. Apple Watch is not included with the Eversense CGM System. Android is a trademark of Google LLC.